XML 26 R14.htm IDEA: XBRL DOCUMENT v3.25.1
REVENUE RECOGNITION
 3 Months Ended
Mar. 31, 2025
Revenue from Contract with Customer [Abstract]  
REVENUE RECOGNITION

NOTE 5 – REVENUE RECOGNITION

 

The Company derives revenue from two primary sources—product revenue and service revenue.

 

Product revenue consists of shipments of:

 

  ● Resale of pharmaceutical products to pharmacies; and
     
  ●

Revenues for our products are recognized and invoiced when the product is shipped to the customer.

 

Revenues for one-time services are recognized at the point in time when services are rendered. Payment terms for products and services are generally 0 to 60 days and the Company has no contract assets or liabilities.

 

Revenues for the three months ended March 31, 2025 and 2024 were $10,258 and $0, respectively. In 2025, all revenue was product revenue.